Literature DB >> 8657528

Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease.

F D Armstrong1, R J Thompson, W Wang, R Zimmerman, C H Pegelow, S Miller, F Moser, J Bello, A Hurtig, K Vass.   

Abstract

OBJECTIVE: Brain magnetic resonance imaging (MRI) and neuropsychological evaluations were conducted to determine whether neuroradiographic evidence of infarct in children with sickle cell disease between ages 6 and 12 years would result in impairment in cognitive and academic functioning. METHOD AND
DESIGN: Children enrolled in the Cooperative Study of Sickle Cell Disease were evaluated with brain MRI and neuropsychological evaluation. Completed studies were obtained for 194 children, 135 with HbSS. MRIs were categorized according to the presence of T2-weighted, high-intensity images suggestive of infarct and were further categorized on the basis of a clinical history of cerebrovascular accident (CVA). An abnormal MRI but no clinical history of CVA was classified as a silent infarct. Neuropsychological evaluations included assessment of both global intellectual functioning and specific academic and neuropsychological functions.
RESULTS: Central nervous system (CNS) abnormalities were identified on MRI in 17.9% of the children (22.2% of children homozygous for HbS), and a clinical history of CVA (N = 9, 4.6%) was identified in only children with HbSS disease. Subsequent analyses examined only children with HbSS. Children with a history of CVA performed significantly poorer than children with silent infarcts or no MRI abnormality on most neuropsychological evaluation measures. Children with silent infarcts on MRI performed significantly poorer than children with no MRI abnormality on tests of arithmetic, vocabulary, and visual motor speed and coordination.
CONCLUSIONS: These results substantiate the importance of careful evaluation, educational planning, and medical intervention for CNS-related complications in children with sickle cell disease.

Entities:  

Mesh:

Year:  1996        PMID: 8657528

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  85 in total

1.  Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.

Authors:  Miguel R Abboud; Eunsil Yim; Khaled M Musallam; Robert J Adams
Journal:  Blood       Date:  2011-06-01       Impact factor: 22.113

2.  Cognitive functioning in children from Nigeria with sickle cell anemia.

Authors:  Olubusola B Oluwole; Robert B Noll; Daniel G Winger; Olu Akinyanju; Enrico M Novelli
Journal:  Pediatr Blood Cancer       Date:  2016-07-09       Impact factor: 3.167

3.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

Review 4.  Stroke in children with sickle cell anaemia: aetiology and treatment.

Authors:  C H Pegelow
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

5.  Supporting family adaptation to presymptomatic and "untreatable" conditions in an era of expanded newborn screening.

Authors:  Donald B Bailey; F Daniel Armstrong; Alex R Kemper; Debra Skinner; Steven F Warren
Journal:  J Pediatr Psychol       Date:  2008-03-30

6.  Parent education and biologic factors influence on cognition in sickle cell anemia.

Authors:  Allison A King; John J Strouse; Mark J Rodeghier; Bruce E Compas; James F Casella; Robert C McKinstry; Michael J Noetzel; Charles T Quinn; Rebecca Ichord; Michael M Dowling; J Philip Miller; Michael R Debaun
Journal:  Am J Hematol       Date:  2014-02       Impact factor: 10.047

7.  Multivariate surface-based analysis of corpus callosum in patients with sickle cell disease.

Authors:  Yaqiong Chai; Yi Lao; Yicen Li; Chaoran Ji; Sharon O'Neil; Yalin Wang; Natasha Lepore; John Wood
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-01-26

8.  Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition.

Authors:  R Scott Mackin; Philip Insel; Diana Truran; Elliot P Vichinsky; Lynne D Neumayr; F D Armstrong; Jeffrey I Gold; Karen Kesler; Joseph Brewer; Michael W Weiner
Journal:  Neurology       Date:  2014-02-12       Impact factor: 9.910

9.  Working Memory in Children With Neurocognitive Effects From Sickle Cell Disease: Contributions of the Central Executive and Processing Speed.

Authors:  Kelsey E Smith; Jeffrey Schatz
Journal:  Dev Neuropsychol       Date:  2016-10-19       Impact factor: 2.253

10.  Capturing PLMS and their variability in children with sickle cell disease: does ankle activity monitoring measure up to polysomnography?

Authors:  Valerie E Rogers; Paul R Gallagher; Carole L Marcus; Kwaku Ohene-Frempong; Joel T Traylor; Thornton B A Mason
Journal:  Sleep Med       Date:  2012-07-25       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.